Europe Medical Foods for Inborn Errors of Metabolism Market – Industry Trends and Forecast to 2027

  • Medical Devices
  • Published Report
  • May 2020
  • Europe
  • 350 Pages
  • No of Tables: 219
  • No of Figures: 24

Europe Medical Foods For Inborn Errors of Metabolism Market, By Product (Amino Acid, Glytactin with GMP Amino Acid-Modified Infant Formula With Iron, Low-Calcium/Vitamin D-Free Infant Formula With Iron, Low Protein Food and Others), Age Group (Infants, Weaning, Adolescent, Adults), Diseases (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I Renal Disease, Tyrosinemia Types I and II, Urea Cycle Disorders and Others), Forms (Powder, Liquids, gels and Others), Packaging (Can, Jar, Packets, Bottle and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drugs Stores, Online Pharmacies and Others), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Poland, Denmark Turkey and  rest of Europe) Industry Trends & Forecast to 2027      

Europe Medical Foods for Inborn Errors of Metabolism Market Market Analysis and Insights: Europe Medical Foods for Inborn Errors of Metabolism Market 

Medical foods for inborn errors of metabolism market are expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 11.9% in the forecast period of 2020 to 2027 and is expected to reach USD 1,079.57 million by 2027. Rising incidence of inborn errors of metabolism, preference of dietary supplements over enzyme substitution therapy are the major drivers which propelled the demand of the market in the forecast period.

The inborn errors of metabolism are a group of disorders in which the body fails to convert the food into energy. Due to the mutations in genes there is less or no production of a specific enzyme, these enzymes are responsible for breaking down certain substances. This leads to accumulation of some substances which are toxic and leads to severe complications. In order to treat these disorders, they are given specific diets which are also known as medical foods under the supervision of physicians

Medical food demand has increased as compared to the precise year with increasing expenditure on medical food along with introduction of innovative products for new indications. In addition demand of medical food has increased because of government initiatives and programs for creating awareness about IEM. Further inadequate reimbursement scenario is expected to restraint the usage of medical food and is expected to slow down the growth of the medical food market in the forecasted period.  

This Medical Foods For Inborn Errors of Metabolism Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.  

Europe Medical Foods for Inborn Errors of Metabolism Market Europe Medical Foods for Inborn Errors of Metabolism Market Scope and Market Size

Medical foods for inborn errors of metabolism market are segmented into six segments on the basis of products, age group, diseases, forms, packaging and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of products, global medical foods for inborn errors of metabolism market is segmented into amino acid, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron, low protein food and others.  The amino acid segment is dominating as more number of people are suffering from amino acid metabolic disorders and more amino acid based products are generated.
  • On the basis of age group, global medical foods for inborn errors of metabolism market are segmented into infants, weaning, adolescent and adults. Infants segment is dominating as more number of these errors are reported in the infants with the increase in the number of new bon screening procedures.
  • On the basis of diseases, global medical foods for inborn errors of metabolism market is segmented into phenylketonuria(PKU), maple syrup urine disease (MSUD), homocystinuria, methylmalonic acidemia, organic acidurias, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric acidemia type I, renal disease, tyrosinemia types I and II, urea cycle disorders and others. Phenylketonuria (PKU) segment is dominating the market as its incidence is high in all diseases in inborn error of metabolism. More number of products manufactured by the companies is made to cure PKU disease. For instance, Abbott, Nutricia and BioMarin are the major companies involved in providing medical food for PKU disease. 
  • On the basis of forms, global medical foods for inborn errors of metabolism market are segmented into powder, liquids, gels and others.  Powder form is the dominating the segment as powder is easy to store and also its shelf life is good. 
  • On the basis of packaging, global medical foods for inborn errors of metabolism market is segmented into can, jar, packets, bottle and others. The can segment is dominating as it keeps the food safe and it is also easy to store the products in can.
  • On the basis of distribution channel, the global medical foods for inborn errors of metabolism market  is segmented into retail pharmacies, hospital pharmacies, online pharmacies, drugs store and other. The retail pharmacy segment is dominating as people can take prescribed drugs from there on great discounts moreover there is a large variety of products available.

Medical Foods for Inborn Errors of Metabolism Market Country Level Analysis

Medical foods for inborn errors of metabolism market is segmented into six notable segments on the basis of product, age group, diseases, forms, packaging and distribution channel.

The countries covered in the medical foods for inborn errors of metabolism market report are the Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Denmark, Poland, Turkey and rest of Europe.   

Germany is dominating the European market with the increase in the number of new born screening procedures and also due to the increasing recommendations by the doctors to use medical food.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. 

Increasing collaboration by the player for development of new advance Medical Foods is Creating New Opportunities for Players in the Medical Foods for Inborn Errors of Metabolism Market

Medical foods for inborn errors of metabolism market also provides you with detailed market analysis for every country growth in particular industry with medical food sales, impact of advancement in the medical foods for inborn errors of metabolism and changes in regulatory scenarios with their support for the medical foods for inborn errors of metabolism market. The data is available for historic period 2010 to 2018. 

Competitive Landscape and Medical Foods for Inborn Errors of Metabolism Market Share Analysis

Medical foods for inborn errors of metabolism market competitive landscape provide details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to medical foods for inborn errors of metabolism market.

The major players covered in the report are Nestlé Health Science (A subsidiary of Nestle), Nutricia (A subsidiary of Danone), Abbott, Mead Johnson & Company, LLC.(A subsidiary of Reckitt Benckiser),BioMarin Pharmaceutical, Ajinomoto Cambrooke, Inc. (A subsidiary of Ajinomoto), Poa Pharma, PKU-MDmil, Dr.Schar AG/SPA Primus Pharmaceuticals, Inc., APR, Promin Metabolics among other domestic and Europe players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the medical foods for inborn errors of metabolism.

For instance,

  • In March 2019, Nutricia opened a sustainable plant in Netherlands. The Nutricia Cuijk plant was a humungous investment and has increased the volume of specialized infant formula along with the increased revenue generation in the market.
  • In June, Mead Johnson & Company, LLC. announced that it has been completely merged with Reckitt Benckiser Group plc (RB).  It was expected that the Mead Johnson brand and business continued to boom with Reckitt Benckiser plc groups’ good innovation and marketing process.

Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the medical foods for inborn errors of metabolism market which also provides the benefit for organisation to improve their offering for medical foods.

Customization Available: Europe Medical Foods for Inborn Errors of Metabolism Market 

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 COSTS OF MEDICAL FOODS

TABLE 2 ESTIMATED COSTS PER YEAR FOR MEDICAL FOODS FOR IEM, BY SELECTED AGE GROUP

TABLE 3 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 4 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 5 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 6 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 7 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 8 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 9 EUROPE LOW PROTEIN FOODS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 10 EUROPE GLYTACTIN WITH GMP AMINO ACID-MODIFIED INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 EUROPE LOW-CALCIUM/VITAMIN D-FREE INFANT FORMULA WITH IRON IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 12 EUROPE OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 14 EUROPE INFANTS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 15 EUROPE WEANING IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 16 EUROPE ADOLESCENT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 17 EUROPE ADULT IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 18 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 19 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 20 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 21 EUROPE TYROSINEMIA TYPES I AND II IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 22 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 EUROPE MAPLE SYRUP URINE DISEASE(MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 24 EUROPE HOMOCYSTINURIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 25 EUROPE GLUTARIC ACIDEMIA TYPE I IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 26 EUROPE UREA CYCLE DISORDERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 EUROPE METHYLMALONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 28 EUROPE ISOVALERIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 EUROPE ORGANIC ACIDURIAS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 30 EUROPE RENAL DISEASE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 EUROPE PROPIONIC ACIDEMIA IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 EUROPE DISORDERS OF LEUCINE METABOLISM IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 33 EUROPE OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 34 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 35 EUROPE POWDER IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 36 EUROPE LIQUID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 37 EUROPE OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 38 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 39 EUROPE CAN IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 40 EUROPE PACKET IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 41 EUROPE BOTTLE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 42 EUROPE JAR IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 43 EUROPE OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 44 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTON CHANNEL, 2018-2027 (USD MILLION)

TABLE 45 EUROPE RETAIL PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 46 EUROPE HOSPITAL PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 47 EUROPE DRUGS STORES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 48 EUROPE ONLINE PHARMACIES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 49 EUROPE OTHERS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 50 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 51 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 52 EUROPE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 53 EUROPE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 54 EUROPE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 55 EUROPE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 56 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 57 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 58 EUROPE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 59 EUROPE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 60 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 61 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 62 EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 63 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 64 GERMANY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 65 GERMANY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 66 GERMANY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 67 GERMANY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 68 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 69 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 70 GERMANY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 71 GERMANY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 72 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 73 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 74 GERMANY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 75 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 76 FRANCE AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 77 FRANCE SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 78 FRANCE AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 79 FRANCE PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 80 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 81 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 82 FRANCE PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 83 FRANCE MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 84 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 85 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 86 FRANCE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 87 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 88 U.K. AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 89 U.K. SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 90 U.K. AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 91 U.K. PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 92 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 93 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 94 U.K. PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 95 U.K. MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 96 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 97 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 98 U.K. MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 99 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 100 ITALY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 101 ITALY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 102 ITALY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 103 ITALY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 104 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 105 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 106 ITALY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 107 ITALY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 108 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 109 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 110 ITALY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 111 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 112 SPAIN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 113 SPAIN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 114 SPAIN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 115 SPAIN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 116 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 117 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 118 SPAIN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 119 SPAIN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 120 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 121 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 122 SPAIN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 123 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 124 SWITZERLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 125 SWITZERLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 126 SWITZERLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 127 SWITZERLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 128 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 129 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 130 SWITZERLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 131 SWITZERLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 132 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 133 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 134 SWITZERLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 135 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 136 NETHERLANDS AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 137 NETHERLANDS SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 138 NETHERLANDS AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 139 NETHERLANDS PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 140 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 141 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 142 NETHERLANDS PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 143 NETHERLANDS MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 144 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 145 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 146 NETHERLANDS MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 147 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 148 BELGIUM AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 149 BELGIUM SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 150 BELGIUM AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 151 BELGIUM PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 152 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 153 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 154 BELGIUM PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 155 BELGIUM MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 156 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 157 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 158 BELGIUM MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 159 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 160 DENMARK AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 161 DENMARK SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 162 DENMARK AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 163 DENMARK PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 164 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 165 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 166 DENMARK PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 167 DENMARK MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 168 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 169 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 170 DENMARK MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 171 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 172 RUSSIA AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 173 RUSSIA SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 174 RUSSIA AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 175 RUSSIA PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 176 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 177 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 178 RUSSIA PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 179 RUSSIA MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 180 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 181 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 182 RUSSIA MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 183 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 184 SWEDEN AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 185 SWEDEN SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 186 SWEDEN AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 187 SWEDEN PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 188 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 189 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 190 SWEDEN PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 191 SWEDEN MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 192 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 193 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 194 SWEDEN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 195 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 196 TURKEY AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 197 TURKEY SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 198 TURKEY AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 199 TURKEY PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 200 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 201 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 202 TURKEY PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 203 TURKEY MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 204 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 205 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 206 TURKEY MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 207 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 208 POLAND AMINO ACID IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 209 POLAND SINGLE AMINO ACIDS IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 210 POLAND AMINO ACID MIXTURES IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 211 POLAND PHENYLADE IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 212 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY AGE GROUP, 2018-2027 (USD MILLION)

TABLE 213 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISEASES, 2018-2027 (USD MILLION)

TABLE 214 POLAND PHENYLKETONURIA (PKU) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 215 POLAND MAPLE SYRUP URINE DISEASE (MSUD) IN MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

TABLE 216 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY FORM, 2018-2027 (USD MILLION)

TABLE 217 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PACKAGING, 2018-2027 (USD MILLION)

TABLE 218 POLAND MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 219 REST OF EUROPE MEDICAL FOODS FOR INBORN ERRORS OF METABOLISM MARKET, BY PRODUCTS, 2018-2027 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions